Back to SSA Annual Conference 2021

SSA Annual Conference 2021

Links to slide presentations, authors’ biographies and abstracts can be found below. Audio and video recordings will be made available over the coming months.

Delegate posters, abstracts and authors’ biographies are available now via the buttons below and at the bottom of the page.

Click here for Delegate Speakers’ presentations

Click here for Delegate Posters

Society lecture 2021

SSA Annual Conference 2021

Society Lecture 2021: Addiction Recovery: From Culture to Science

Dr John Kelly (2021)

SSA-funded researchers

Quitting in the time of Covid? Associations of the pandemic with changes in smoking, drinking, and quitting in England

Dr Sarah Jackson

Exploration of patients’ beliefs, acceptability, and experience of mobile telephone-delivered Contingency Management

Dr Carol-Ann Getty (2021)

Examining the implementation and early impact of the Public Health (Alcohol) Act in Ireland: Findings from two data sources

Dr Nathan Critchlow

Addiction training opportunities in Europe: a joint SSA/EUFAS symposium

Plenary session

EUFAS European Addiction Research Award 2021 lecture: Addiction research training in a post-Brexit, post-Covid world

Professor Anne Lingford-Hughes

Training in addiction medicine and psychology throughout Europe

Professor Jørgen G Bramness

Improving addiction competencies in the UK

Professor Julia Sinclair

Addiction training opportunities in Europe: a joint SSA/EUFAS symposium – Q&A

Professor Colin Drummond

The challenge of benzodiazepine use in the context of escalating drug deaths

Members and associates symposium

Prevalence and determinants of non-prescribed benzodiazepine use and related harms among a national sample of people who inject drugs

Dr Andrew McAuley (2021)

Experiences of non-prescribed benzodiazepine use by people on opioid agonist therapy in a city centre treatment service

Dr Trina Ritchie

Clinical management of problematic BZD use in Addictions: the views of clinicians and people who use drugs; prescribing practices and patient outcomes

Mr Joe Schofield (2021)

The challenge of benzodiazepine use in the context of escalating drug deaths – Q&A

Dr Sarah Welch

Avon Longitudinal Study of Parents and Children (ALSPAC) 1 - What influences the development of substance use harms?

Members and associates symposium

Adverse childhood experiences and trajectories of adolescent cannabis use frequency

Dr Lindsey Hines

Examining pathways between genetic liability for schizophrenia and patterns of tobacco and cannabis use in adolescence

Dr Hannah Jones

Investigating the association between alcohol consumption and dependence during adolescence, and risk of depression in young adulthood

Dr Gemma Lewis

Avon Longitudinal Study of Parents and Children (ALSPAC) – What influences the development of substance use harms? – Q&A

Professor Matt Hickman

In recognition of Professor Malcolm Lader

Special session

In recognition of Professor Malcolm Lader, past President of the SSA and past President of the British Association for Psychopharmacology

Professor David Baldwin

Patient experiences and perceptions of receiving benzodiazepines and z-drugs: lessons for safer prescribing

Dr Coral Sirdifield

Prescriptions of gabapentinoids – what should we learn from the insights of Malcolm Lader?

Dr Maryse Lapeyre-Mestre

Autism, addictive behaviour and substance use disorders – A priority setting partnership

Special session

Understanding the links between autism, addictive behaviour, and substance use disorders – A Priority Setting Partnership

Janine Robinson - Consultant Clinical Psychologist (2021)

Behavioural addictions and autistic traits – what do we know so far?

Professor Sam Chamberlain

Autism and alcohol and other substances

Mrs Betul Aslan

Responding to the use of anabolic androgenic steroids

Members and associates symposium

The public health implications of anabolic androgenic steroid use for muscular enhancement

Dr Harrison Pope

Anabolic androgenic steroids’ effect on the brain

Dr Astrid Bjørnebekk

The United Kingdom response to the use of anabolic androgenic steroid use for muscular enhancement.

Prof Jim McVeigh

Responding to the use of anabolic androgenic steroids – Q&A

Professor Owen Bowden-Jones

Alcohol and suicidal behaviour: clinical features, trends and interventions

Members and associates symposium

Alcohol use and its association with suicide attempt, suicidal thought, and self-harm in two successive nationally representative English household samples

Sarah Ledden

One size fits all? The different forms of alcohol use in suicidal crisis and their associations with repeated crisis care and death

Mr John Robins

Development of a suicide prevention intervention for Emergency Department attendees presenting with self-harm and substance misuse: a Delphi method study

Dr Prianka Padmanathan

Alcohol and suicidal behaviour: clinical features, trends and interventions – Q&A

Professor Owen Bowden-Jones

Global perspectives on Covid-19 and substance misuse: A report from the ICARA webinar series

Special session

Global perspectives on Covid-19 and substance misuse: A report from the ICARA webinar series

Professor Niamh Fitzgerald

Global perspectives on Covid-19 and substance misuse: A report from the ICARA webinar series

Dr Rachel O'Donnell (2021)

Global perspectives on Covid-19 and substance misuse: A report from the ICARA webinar series

Dr Claire Wilkinson

Global perspectives on Covid-19 and substance misuse: A report from the ICARA webinar series

Rosalie Liccardo Pacula

Youth in Iceland model: Showcasing the work and findings of the part-SSA-funded, Youth in Iceland Model project

Special session

Introduction to the SSA-funded Youth in Iceland Model (YiIM) project

Dr Hannah Carver

Why prevention is needed in Dundee – the case of the Youth in Iceland Model

Pat Tyrie

Creating comics for the Youth in Iceland Model project

Millie Strachan

Youth in Iceland model: Showcasing the work and findings of this part-SSA-funded project – Q&A

Chair: Dr Arun Dhandayudham

Improving drug treatment and recovery: Independent Review of Drugs Part 2

Plenary session

Improving drug treatment and recovery: Independent Review of Drugs Part 2

Professor Dame Carol Black

Complete list of themes, speakers & posters

DELEGATE SPEAKERS

View full list

POSTERS

View full list